Document is current
Any future updates will be listed below
-
Authors
Clemens, Kristin
Zhdanava, Maryia https://orcid.org/0000-0002-7995-2578
Teeple, Amanda
Voegel, Arthur
Shah, Aditi
Bowrey, Hannah E.
Tardif-Samson, Anabelle
Pilon, Dominic
Joshi, Kruti
-
Funding
Funding for this research was provided by:
Johnson & Johnson Innovative Medicine
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 18 July 2025
First Online: 15 August 2025
Declarations
:
: Kristin Clemens is part of the Advanced Practice Provider Publication for Janssen Neuroscience US Medical Affairs, Medical Affairs Steering Committee September Advisory Board, consultant for Sage Therapeutics, Inc., speaker for AbbVie, and an adjunct professor at George Mason University. Maryia Zhdanava, Arthur Voegel, Aditi Shah, Anabelle Tardif-Samson and Dominic Pilon are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Johnson & Johnson Innovative Medicine, which funded the development and conduction of this study. Amanda Teeple, Hannah E Bowrey, and Kruti Joshi are employees of Johnson & Johnson Innovative Medicine and stockholders of Johnson & Johnson.
: This study was considered exempt research under 45 CFR § 46.104(d)(4) as it involved only the secondary use of data that were de-identified in compliance with the Health Insurance Portability and Accountability Act (HIPAA), specifically, 45 CFR § 164.514.
